Risk score methodologies are essential to getting the most from your healthcare and benefits data. Here's why Artemis Health is switching to Milliman Advanced Risk Adjusters (MARA) to replace the Johns Hopkins methodology.
What’s the Cost of a Severe Peanut Allergy?
It’s that time of year again—the time of year when moms and dads around the country send their little angels back to school. Some of you are celebrating, and some of you are wistfully thinking about how fast they grow up. And there’s a good chance some of you are looking for lunch ideas that don’t include peanut butter sandwiches.
How Specialty Drugs Affect Your Rx Spend (And What You Can Do About It)
Experts are estimating that specialty Rx will account for 50% of total spending by 2018. Let’s take a closer look at this segment of spending and how employers can help stop the rising tide.
Artemis Health Secures $16 Million Series B Round to Equip Employers with Actionable Employment Benefits Data
Artemis Health received $16 million in Series B funding led by F-Prime Capital (the venture capital funds of FMR LLC, the parent company of Fidelity Investments), with participation from previous investors Maverick Ventures and Kickstart Seed Fund. This is the second major round of funding Artemis Health has raised in 12 months.
How Artemis is Working with Hospitals to Address their Data Challenges
Artemis Health is finding more and more hospitals are interested in optimizing their benefits using data. They’re seeking transparency tools, easy data analysis, and the means to find waste in their spending.
Evaluating a Data Warehouse – How To Get It Right.
The most expensive software you will ever purchase is the software that no one uses. Artemis Health wants to help you find the right data warehouse for your benefits team, employees, and organization.